We are live on ! Find out more
ANGO icon

AngioDynamics

121 hedge funds and large institutions have $302M invested in AngioDynamics in 2016 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 50 increasing their positions, 34 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

919% more call options, than puts

Call options by funds: $1.58M | Put options by funds: $155K

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

47% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 34

8% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 12

3% more capital invested

Capital invested by funds: $293M → $302M (+$9.46M)

0% more funds holding

Funds holding: 121121 (0)

Holders
121
Holders Change
Holders Change %
0%
% of All Funds
3.22%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
13
Increased
50
Reduced
34
Closed
12
Calls
$1.58M
Puts
$155K
Net Calls
+$1.43M
Net Calls Change
+$1.16M
Name Holding Trade Value Shares
Change
Change in
Stake
ARTA
126
A.R.T. Advisors
New York
-$147K -12,154 Closed
Tudor Investment Corp
127
Tudor Investment Corp
Connecticut
-$123K -10,139 Closed
TRCT
128
Tower Research Capital (TRC)
New York
-$32K -2,622 Closed
Group One Trading
129
Group One Trading
Illinois
-$28.1K -2,547 Closed
US Bancorp
130
US Bancorp
Minnesota
-$24K -2,000 Closed
CG
131
Cutler Group
California
-$8K -741 Closed
MFS
132
MSI Financial Services
Massachusetts
-$2K -141 Closed
Fifth Third Bancorp
133
Fifth Third Bancorp
Ohio
-$1K -74 Closed

ANGO Hedge Fund Activity: Q1 2016 in Review

121 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q1 2016, worth a combined $302M — up 3.2% from $293M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ANGO positions and 12 closed out — a net gain of 1 holder — while 50 added to existing stakes and 34 trimmed.

The largest buyer was JP Morgan Chase, opening a new position worth an estimated $3.19M. The largest seller was Millennium Management, cutting an estimated $2.76M.

  • 121 institutional investors held AngioDynamics (ANGO) as of Q1 2016, unchanged from Q4 2015.
  • Funds reported $302M of AngioDynamics stock for Q1 2016, up 3.2% quarter-over-quarter.
  • 13 funds opened new AngioDynamics positions in Q1 2016 and 12 closed out, a net change of +1 holder.
  • The largest AngioDynamics buyer in Q1 2016 was JP Morgan Chase, an estimated $3.19M added.
  • The largest AngioDynamics seller in Q1 2016 was Millennium Management, an estimated $2.76M sold.

Based on aggregated 13F filings for Q1 2016.